AAPL   322.18 (+0.10%)
MSFT   183.54 (+0.39%)
FB   229.97 (-0.84%)
AMZN   2,466.88 (-0.17%)
NVDA   351.37 (-0.25%)
BABA   213.60 (+3.40%)
MU   46.49 (+0.30%)
TSLA   894.99 (-0.35%)
AMD   52.89 (-1.40%)
T   30.91 (-0.06%)
GILD   73.23 (-2.57%)
DIS   118.65 (-0.10%)
NFLX   424.46 (-0.34%)
BAC   24.81 (+0.81%)
BA   153.51 (+1.40%)
AAPL   322.18 (+0.10%)
MSFT   183.54 (+0.39%)
FB   229.97 (-0.84%)
AMZN   2,466.88 (-0.17%)
NVDA   351.37 (-0.25%)
BABA   213.60 (+3.40%)
MU   46.49 (+0.30%)
TSLA   894.99 (-0.35%)
AMD   52.89 (-1.40%)
T   30.91 (-0.06%)
GILD   73.23 (-2.57%)
DIS   118.65 (-0.10%)
NFLX   424.46 (-0.34%)
BAC   24.81 (+0.81%)
BA   153.51 (+1.40%)
AAPL   322.18 (+0.10%)
MSFT   183.54 (+0.39%)
FB   229.97 (-0.84%)
AMZN   2,466.88 (-0.17%)
NVDA   351.37 (-0.25%)
BABA   213.60 (+3.40%)
MU   46.49 (+0.30%)
TSLA   894.99 (-0.35%)
AMD   52.89 (-1.40%)
T   30.91 (-0.06%)
GILD   73.23 (-2.57%)
DIS   118.65 (-0.10%)
NFLX   424.46 (-0.34%)
BAC   24.81 (+0.81%)
BA   153.51 (+1.40%)
AAPL   322.18 (+0.10%)
MSFT   183.54 (+0.39%)
FB   229.97 (-0.84%)
AMZN   2,466.88 (-0.17%)
NVDA   351.37 (-0.25%)
BABA   213.60 (+3.40%)
MU   46.49 (+0.30%)
TSLA   894.99 (-0.35%)
AMD   52.89 (-1.40%)
T   30.91 (-0.06%)
GILD   73.23 (-2.57%)
DIS   118.65 (-0.10%)
NFLX   424.46 (-0.34%)
BAC   24.81 (+0.81%)
BA   153.51 (+1.40%)
Log in

NYSEARCA:ZBIOProshares Ultraproshort Nasdaq Biotechnology Stock Price, Forecast & News

$10.02
-0.07 (-0.69 %)
(As of 06/2/2020 02:27 PM ET)
Add
Today's Range
$10.02
Now: $10.02
$10.02
50-Day Range
$10.02
MA: $10.06
$10.09
52-Week Range
$8.28
Now: $10.02
$18.64
VolumeN/A
Average Volume32,378 shs
Market Capitalization$2.51 million
P/E RatioN/A
Dividend Yield0.36%
BetaN/A

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.83 out of 5 stars


Basic Details

Issuer
Fund NamePROSHARES ULTRAPROSHORT NASDAQ BIOTECHNOLOGY
Tax Classification
SymbolNYSEARCA:ZBIO
Inception Date1/1/2100
Fund Manager
WebN/A
PhoneN/A

Fund Focus

Asset Class
Benchmark
Category
Focus
Development Level
Region

Fund Statistics

Assets Under Management$2.51 million
Average Daily Volume$36,053.50
Discount/Premium-0.04%

ETF Expenses

Management Fee0.75%
Other Expenses1.02%
Total Expenses1.77%
Fee Waiver-0.82%
Net Expenses0.95%

Administrator, Advisor and Custodian

Administrator
Advisor
Custodian
Distributor
Transfer Agent
Trustee
Lead Market Maker

Receive ZBIO News and Ratings via Email

Sign-up to receive the latest news and ratings for ZBIO and its competitors with MarketBeat's FREE daily newsletter.

Currency Exposure of Proshares Ultraproshort Nasdaq Biotechnology (NYSEARCA:ZBIO)

Proshares Ultraproshort Nasdaq Biotechnology (NYSEARCA:ZBIO) Frequently Asked Questions

How has Proshares Ultraproshort Nasdaq Biotechnology's stock been impacted by COVID-19 (Coronavirus)?

Proshares Ultraproshort Nasdaq Biotechnology's stock was trading at $11.68 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, ZBIO shares have decreased by 14.2% and is now trading at $10.0204. View which stocks have been most impacted by Coronavirus.

Has Proshares Ultraproshort Nasdaq Biotechnology been receiving favorable news coverage?

Headlines about ZBIO stock have trended positive on Tuesday, according to InfoTrie. The research group identifies negative and positive media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Proshares Ultraproshort Nasdaq Biotechnology earned a media sentiment score of 2.6 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View the latest news aboutProshares Ultraproshort Nasdaq Biotechnology.

What other stocks do shareholders of Proshares Ultraproshort Nasdaq Biotechnology own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Proshares Ultraproshort Nasdaq Biotechnology investors own include AIM ImmunoTech (AIM), Allied Healthcare Products (AHPI), AEGON (AGN), Aerie Pharmaceuticals (AERI), Adverum Biotechnologies (ADVM), Adaptimmune Therapeutics (ADAP), ACADIA Pharmaceuticals (ACAD), Abbott Laboratories (ABT), Abeona Therapeutics (ABEO) and AbbVie (ABBV).

What is Proshares Ultraproshort Nasdaq Biotechnology's stock symbol?

Proshares Ultraproshort Nasdaq Biotechnology trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "ZBIO."

How do I buy shares of Proshares Ultraproshort Nasdaq Biotechnology?

Shares of ZBIO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Proshares Ultraproshort Nasdaq Biotechnology's stock price today?

One share of ZBIO stock can currently be purchased for approximately $10.02.

How big of a company is Proshares Ultraproshort Nasdaq Biotechnology?

Proshares Ultraproshort Nasdaq Biotechnology has a market capitalization of $2.51 million.

This page was last updated on 6/2/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.